1. Chief Executive Officer (CEO): Timothy P. Herbert
Timothy P. Herbert is the President and Chief Executive Officer of Inspire Medical Systems. He has been in this role since 2018 and has over 25 years of experience in the medical device industry. Prior to joining Inspire, Herbert worked at St. Jude Medical, Cardiovascular Systems Inc., and ev3.
2. Chief Financial Officer (CFO): Richard Buchholz
Richard Buchholz serves as the Chief Financial Officer of Inspire Medical Systems, a position he has held since 2020. He brings more than 20 years of experience in finance and accounting. Before joining Inspire, Buchholz worked at Tactile Systems Technology and Entellus Medical.
3. Director: Myriam J. Curet, M.D.
Myriam J. Curet, M.D. is a Director at Inspire Medical Systems.
4. Director: Cynthia B. Burks
Cynthia B. Burks serves as a Director at Inspire Medical Systems.
5. Director: Shelley G. Broader
Shelley G. Broader is a Director at Inspire Medical Systems.
6. Director: Dana G. Mead, Jr.
Dana G. Mead, Jr. serves as a Director at Inspire Medical Systems.
7. Chair of the Board of Directors: Marilyn Carlson Nelson
Marilyn Carlson Nelson is the Chair of the Board of Directors at Inspire Medical Systems.
8. Director: Georgia Melenikiotou
Georgia Melenikiotou serves as a Director at Inspire Medical Systems.
9. Director: Shawn T. McCormick
Shawn T. McCormick is a Director at Inspire Medical Systems.
10. Director: Gary L. Ellis
Gary L. Ellis serves as a Director at Inspire Medical Systems.
11. Director: Jerry C. Griffin, M.D.
Jerry C. Griffin, M.D. is a Director at Inspire Medical Systems.
12. Director: Casey M. Tansey
Casey M. Tansey serves as a Director at Inspire Medical Systems.,
Inspire Medical Systems inc currently has 1333 employees.
News about Inspire Medical Systems inc Key Personnel |
In a recent press release, Inspire Medical Systems, Inc. (NYSE: INSP) announced the FDA s approval of its Inspire V therapy system. This marks a significant milestone for the medical technology company, which specializes in developing minimally invasive solutions for patients suffering from obstructive sleep apnea (OSA). However, this positive news comes amidst financial difficulties, as Inspire Medical Systems recorded a net loss and a decline in return on investment (ROI) in the first quarter of 2024. In this article, we will delve into the facts surrounding these developments and assess their impact on the company s future.
Factual overview:
Inspire Medical Systems has successfully obtai...
|
Inspire Medical Systems, Inc. has recently made a significant stride in France with the publication of reimbursement for its innovative therapy aimed at treating obstructive sleep apnea (OSA). This favorable development comes at a crucial time for the company, as it grapples with a recorded net loss of $16 million in the first quarter of 2024, resulting in a negative return on investment (ROI) of -2.81%. Despite these financial setbacks, Inspire remains committed to providing minimally invasive solutions for OSA patients and moving forward in the healthcare sector.
I. Inspire Medical Systems’ Reimbursement Announcement:
Inspire Medical Systems, Inc. proudly shared news of the publication ...
|
